IsoRay Stock Price, News & Analysis (NYSEAMERICAN:ISR)

$0.41 -0.01 (-2.38 %)
(As of 12/13/2017 11:56 AM ET)
Previous Close$0.42
Today's Range$0.41 - $0.43
52-Week Range$0.38 - $0.70
Volume79,300 shs
Average Volume114,506 shs
Market Capitalization$23.05 million
P/E RatioN/A
Dividend YieldN/A


IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy procedure places radioactive seeds as close as possible to (in or near) the cancerous tumor. The Cs-131 includes radioisotope in the treatment of all malignant tumors, such as prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma and pancreatic cancer. The Company's Proxcelan Cesium-131 seed is classified as a Class II device.

Receive ISR News and Ratings via Email

Sign-up to receive the latest news and ratings for ISR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


Trailing EPS($0.11)
Net IncomeN/A
Net Margins-127.66%
Return on Equity-62.92%
Return on Assets-53.80%


Outstanding Shares55,020,000

IsoRay (NYSEAMERICAN:ISR) Frequently Asked Questions

What is IsoRay's stock symbol?

IsoRay trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "ISR."

How were IsoRay's earnings last quarter?

IsoRay, Inc. (NYSEAMERICAN:ISR) announced its quarterly earnings data on Tuesday, November, 14th. The healthcare company reported ($0.03) earnings per share for the quarter. The healthcare company earned $1.21 million during the quarter. IsoRay had a negative return on equity of 62.92% and a negative net margin of 127.66%. View IsoRay's Earnings History.

When will IsoRay make its next earnings announcement?

IsoRay is scheduled to release their next quarterly earnings announcement on Tuesday, February, 6th 2018. View Earnings Estimates for IsoRay.

Where is IsoRay's stock going? Where will IsoRay's stock price be in 2017?

1 brokerages have issued 12-month price targets for IsoRay's stock. Their forecasts range from $3.00 to $3.00. On average, they anticipate IsoRay's stock price to reach $3.00 in the next twelve months. View Analyst Ratings for IsoRay.

Who are some of IsoRay's key competitors?

Who are IsoRay's key executives?

IsoRay's management team includes the folowing people:

  • Thomas C. LaVoy, Chairman of the Board, Chief Executive Officer (Age 56)
  • Mark Austin, Principal Financial Officer, Principal Accounting Officer, Controller (Age 30)
  • William Cavanagh III, Chief Operating, Scientific Officer (Age 51)
  • Michael Krachon, Vice President of Sales and Marketing (Age 45)
  • Alan Hoffmann, Independent Director (Age 55)
  • Michael W. McCormick, Independent Director (Age 53)
  • Philip J. Vitale M.D., Independent Director (Age 70)

How do I buy IsoRay stock?

Shares of IsoRay can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IsoRay's stock price today?

One share of IsoRay stock can currently be purchased for approximately $0.41.

How big of a company is IsoRay?

IsoRay has a market capitalization of $23.05 million.

How can I contact IsoRay?

IsoRay's mailing address is 350 Hills St Ste 106, RICHLAND, WA 99354-5511, United States. The healthcare company can be reached via phone at +1-509-3751202.

MarketBeat Community Rating for IsoRay (ISR)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  56 (Vote Outperform)
Underperform Votes:  31 (Vote Underperform)
Total Votes:  87
MarketBeat's community ratings are surveys of what our community members think about IsoRay and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

IsoRay (NYSEAMERICAN:ISR) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score:
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $3.00$3.00$3.00$3.00
Price Target Upside: 597.67% upside455.45% upside387.80% upside426.32% upside

IsoRay (NYSEAMERICAN:ISR) Consensus Price Target History

Price Target History for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN:ISR) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
11/15/2017Maxim GroupSet Price TargetBuy$3.00View Rating Details
(Data available from 12/13/2015 forward)


IsoRay (NYSEAMERICAN:ISR) Earnings History and Estimates Chart

Earnings by Quarter for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN ISR) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/6/2018N/AView Earnings Details
11/14/2017Q1 2018($0.03)$1.21 millionViewN/AView Earnings Details
9/28/2017Q4 2017($0.01)($0.03)$1.37 millionViewN/AView Earnings Details
5/10/2017Q3 2017($0.02)$1.28 millionViewN/AView Earnings Details
2/8/2017Q2 2017($0.03)$1.03 millionViewN/AView Earnings Details
11/9/2016Q1 2017($0.03)$1.08 millionViewN/AView Earnings Details
9/8/2016Q416($0.02)$1.12 millionViewN/AView Earnings Details
5/10/2016Q316($0.02)$1.16 million$1.20 millionViewN/AView Earnings Details
2/9/2016Q216($0.02)$1.07 million$1.19 millionViewN/AView Earnings Details
11/10/2015Q116($0.01)($0.02)$1.04 million$1.46 millionViewN/AView Earnings Details
9/15/2015Q4($0.01)($0.02)$1.34 millionViewN/AView Earnings Details
5/18/2015Q3($0.01)($0.02)$1.13 million$1.16 millionViewN/AView Earnings Details
2/18/2015Q215($0.02)($0.02)$1.07 millionViewN/AView Earnings Details
5/16/2014Q314($0.03)($0.05)$1.13 million$1.13 millionViewN/AView Earnings Details
11/14/2013Q1($0.06)$1.06 million$1.05 millionViewN/AView Earnings Details
5/15/2013Q313($0.03)($0.02)$1.12 million$1.25 millionViewN/AView Earnings Details
2/14/2013Q2 2013($0.03)($0.03)$1.32 million$0.95 millionViewN/AView Earnings Details
11/14/2012Q113($0.03)($0.03)$1.55 million$1.06 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


IsoRay (NYSEAMERICAN:ISR) Earnings Estimates

No earnings estimates for this company have been tracked by


Dividend History for IsoRay (NYSEAMERICAN:ISR)

No dividend announcements for this company have been tracked by

Insider Trades

IsoRay (NYSEAMERICAN ISR) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for IsoRay (NYSEAMERICAN:ISR)

IsoRay (NYSEAMERICAN ISR) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/24/2017Mark John AustinInsiderBuy2,040$0.49$999.60View SEC Filing  
11/21/2017Mark John AustinInsiderBuy5,400$0.48$2,592.00View SEC Filing  
11/20/2017Michael KrachonVPBuy55,000$0.50$27,500.00View SEC Filing  
11/16/2017Philip J VitaleDirectorBuy30,000$0.44$13,200.00View SEC Filing  
3/10/2017Thomas C LavoyCEOBuy20,000$0.53$10,600.00View SEC Filing  
1/4/2017Philip J VitaleDirectorBuy20,000$0.66$13,200.00View SEC Filing  
12/8/2016Alan HoffmannDirectorBuy20,000$0.57$11,400.00View SEC Filing  
11/17/2016Thomas C LavoyCEOBuy20,000$0.60$12,000.00View SEC Filing  
3/17/2016Thomas C LavoyCEOBuy13,294$0.90$11,964.60View SEC Filing  
3/11/2016Philip J VitaleDirectorBuy10,000$0.93$9,300.00View SEC Filing  
3/11/2016Thomas C LavoyCEOBuy36,706$0.89$32,668.34View SEC Filing  
3/8/2016Michael W MccormickDirectorBuy22,000$0.87$19,140.00View SEC Filing  
11/12/2015Dwight William BabcockCEOBuy25,000$1.27$31,750.00View SEC Filing  
6/9/2015Dwight William BabcockCEOBuy10,000$1.53$15,300.00View SEC Filing  
3/6/2015Thomas C LavoyDirectorBuy10,000$1.66$16,600.00View SEC Filing  
3/5/2015Philip J VitaleDirectorBuy10,000$1.80$18,000.00View SEC Filing  
3/3/2015Dwight William BabcockCEOBuy10,029$1.51$15,143.79View SEC Filing  
11/1/2013Dwight William BabcockCEOBuy25,000$0.53$13,250.00View SEC Filing  
11/28/2012Thomas C LavoyDirectorBuy18,100$0.49$8,869.00View SEC Filing  
11/21/2012Dwight William BabcockCEOBuy10,100$0.40$4,040.00View SEC Filing  
11/19/2012Dwight William BabcockCEOBuy4,800$0.37$1,776.00View SEC Filing  
11/19/2012Robert R KauffmanDirectorBuy25,000$0.38$9,500.00View SEC Filing  
11/16/2012Dwight William BabcockCEOBuy35,100$0.42$14,742.00View SEC Filing  
(Data available from 1/1/2013 forward)


IsoRay (NYSEAMERICAN ISR) News Headlines

ETFs with exposure to IsoRay, Inc. : December 7, 2017ETFs with exposure to IsoRay, Inc. : December 7, 2017 - December 7 at 3:31 PM
IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017IsoRay, Inc. :ISR-US: Earnings Analysis: Q1, 2018 By the Numbers : December 1, 2017 - December 1 at 11:57 AM
IsoRay to Present at the 10th Annual LD Micro Main EventIsoRay to Present at the 10th Annual LD Micro Main Event - November 28 at 9:46 AM
IsoRay, Inc. (ISR) VP Buys $27,500.00 in StockIsoRay, Inc. (ISR) VP Buys $27,500.00 in Stock - November 21 at 4:41 PM
Maxim Group Reiterates "$3.00" Price Target for IsoRay, Inc. (ISR)Maxim Group Reiterates "$3.00" Price Target for IsoRay, Inc. (ISR) - November 19 at 5:38 PM
Philip J. Vitale Acquires 30,000 Shares of IsoRay, Inc. (ISR) StockPhilip J. Vitale Acquires 30,000 Shares of IsoRay, Inc. (ISR) Stock - November 17 at 9:50 PM
IsoRay reports 1Q lossIsoRay reports 1Q loss - November 17 at 8:18 AM
IsoRay, Inc. (ISR) Issues  Earnings ResultsIsoRay, Inc. (ISR) Issues Earnings Results - November 15 at 12:56 PM
IsoRay Announces First Quarter Fiscal 2018 Financial Results - GlobeNewswire (press release)IsoRay Announces First Quarter Fiscal 2018 Financial Results - GlobeNewswire (press release) - November 15 at 3:21 AM
IsoRay, Inc. to Host Earnings CallIsoRay, Inc. to Host Earnings Call - November 15 at 3:21 AM
IsoRay Announces First Quarter Fiscal 2018 Financial ResultsIsoRay Announces First Quarter Fiscal 2018 Financial Results - November 15 at 3:21 AM

SEC Filings


This page is loading this company's SEC Filings. Please wait...

Social Media


IsoRay (NYSEAMERICAN:ISR) Income Statement, Balance Sheet and Cash Flow Statement


IsoRay (NYSEAMERICAN ISR) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.